Advertisement
U.S. markets closed

Virax Biolabs Group Limited (VRAX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.7170-0.0131 (-1.79%)
At close: 04:00PM EDT
0.7110 -0.01 (-0.84%)
After hours: 06:23PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close0.7301
Open0.7800
Bid0.6166 x 100
Ask0.8778 x 100
Day's Range0.7150 - 0.7800
52 Week Range0.7000 - 8.5400
Volume9,315
Avg. Volume96,140
Market Cap1.693M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-17.7000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VRAX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Virax Biolabs Group Limited
    Daily – Vickers Top Insider Picks for 03/13/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more